EFFICACY OF LOW OR STANDARD DOSE RITUXIMAB AS COMPARED TO PONTICELLI'S REGIMEN IN MEMBRANOUS NEPHROPATHY

被引:0
|
作者
Roccatello, Dario [1 ,2 ]
Fenoglio, Roberta [1 ,2 ]
Sciascia, Savino [1 ,2 ]
机构
[1] S Giovanni Bosco Hosp, Turin, Italy
[2] Univ Turin, Turin, Italy
关键词
D O I
暂无
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
FP239
引用
收藏
页数:1
相关论文
共 50 条
  • [21] RITUXIMAB IN THE TREATMENT OF PRIMARY MEMBRANOUS NEPHROPATHY - A COMPARATIVE STUDY OF THREE REGIMEN
    Kohli, Harbir Singh
    Ramachandran, Raja
    Rathi, Manish
    Minz, Ranjana
    Duseja, Ritambhra Nada
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 280 - 280
  • [22] Low-dose Rituximab Monotherapy or in Combination with Tacrolimus Is Effective in Primary Membranous Nephropathy
    Pathak, Vivek
    Venkatesan, Madhav
    Regunathan-Shenk, Renu
    KIDNEY360, 2021, 2 (02): : 336 - 338
  • [23] Low Versus Standard Dose of Rituximab in Adult Patients with Relapsed or Refractory Primary Membranous Nephropathy: Does It Make Any Difference?
    Mirioglu, Safak
    Akyildiz, Arif
    Ucar, Ali Riza
    Uludag, Omer
    Ozluk, Yasemin
    Dirim, Ahmet Burak
    Demir, Erol
    Oto, Ozgur Akin
    Kilicaslan, Isin
    Caliskan, Yasar
    Yazici, Halil
    Turkmen, Aydin
    Sever, Mehmet Sukru
    TURKISH JOURNAL OF NEPHROLOGY, 2023, 32 (03): : 209 - +
  • [24] Combined administration of low-dose predonisolone and cyclosporine in idiopathic membranous nephropathy: Tsukuba’s regimen for IMN
    Jo-ichi Usui
    Kouichi Hirayama
    Satoshi Suzuki
    Akio Koyama
    Kunihiro Yamagata
    Clinical and Experimental Nephrology, 2012, 16 : 654 - 655
  • [25] Combined administration of low-dose predonisolone and cyclosporine in idiopathic membranous nephropathy: Tsukuba's regimen for IMN
    Usui, Jo-ichi
    Hirayama, Kouichi
    Suzuki, Satoshi
    Koyama, Akio
    Yamagata, Kunihiro
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2012, 16 (04) : 654 - 655
  • [26] Tacrolimus combined with corticosteroids versus Modified Ponticelli regimen in treatment of idiopathic membranous nephropathy: Randomized control trial
    Ramachandran, Raja
    Hn, Harsha Kumar
    Kumar, Vinod
    Nada, Ritambhra
    Yadav, Ashok Kumar
    Goyal, Ajay
    Kumar, Vivek
    Rathi, Manish
    Jha, Vivekanand
    Gupta, Krishan Lal
    Sakhuja, Vinay
    Kohli, Harbir Singh
    NEPHROLOGY, 2016, 21 (02) : 139 - 146
  • [27] TACROLIMUS WITH CORTICOSTEROIDS IS INFERIOR TO MODIFIED PONTICELLI REGIMEN IN THE MANAGEMENT OF PRIMARY MEMBRANOUS NEPHROPATHY: RESULTS AT 2 YEARS OF RANDOMIZATION
    Ramachandran, Raja
    Kumar, Vinod
    Nada, Ritambhra
    Kohli, Harbir Singh
    Jha, Vivekanand
    Gupta, Krishan Lal
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 : 77 - 77
  • [28] The Safety and Efficacy of Rituximab-Based Regimen in Atypical Membranous Nephropathy: A Single Center Retrospective Cohort Study
    Liu, Yanan
    Zhang, Shuo
    Hu, Rongrong
    Li, Chao
    Chen, Gang
    Shi, Xiaoxiao
    Liu, Yan
    Zheng, Ke
    Li, Hang
    Wen, Yubing
    Li, Xuemei
    Li, Xuewang
    Xia, Peng
    Qin, Yan
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2023, 16 : 1983 - 1993
  • [29] A Comparative Analysis of Efficacy of Rituximab in Patients with Primary Membranous Nephropathy
    Zhang Qianwei
    Xie Liyi
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [30] Combination of Rituximab and Low-dose Tacrolimus in the Treatment of Refractory Membranous Nephropathy: A Retrospective Cohort Study
    Chen, Xian
    Jiao, Sumin
    Li, Shaomei
    Li, Juan
    Li, Pei
    Song, Fang
    Yan, Zhe
    BALKAN MEDICAL JOURNAL, 2023, 40 (04) : 287 - 293